Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer.
Ann Oncol
; 30(3): 418-423, 2019 03 01.
Article
in En
| MEDLINE
| ID: mdl-30657852
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Lymphocytes, Tumor-Infiltrating
/
Receptor, ErbB-2
/
Trastuzumab
Type of study:
Clinical_trials
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2019
Document type:
Article
Country of publication:
Reino Unido